For instance, CHL1-AS2, one risk biomarker in our research, was negatively correlated to the ovarian cancer prognosis, which might be involved in the development of ovarian endometrium and high expression of lncRNA CHL1-AS2 upregulated in ovarian ectopic endometrium tissues (48, 49). This evidence concerns the gene CHL1 and ovarian carcinoma.